The Scientist

» commercialization

Most Recent

image: TS Picks: CRISPR Patent Edition

TS Picks: CRISPR Patent Edition

By | January 5, 2016

A challenge to the first CRISPR patent just got teeth.

3 Comments

image: Opinion: Translation Nation

Opinion: Translation Nation

By | November 18, 2015

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

0 Comments

image: Who Owns CRISPR?

Who Owns CRISPR?

By | April 3, 2015

With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.

7 Comments

image: Ocean Acidification Harming Shellfish

Ocean Acidification Harming Shellfish

By | December 17, 2014

Researchers determine why larval oysters and mussels are sensitive to reduced pH.

0 Comments

image: Competition for CRISPR Commercialization

Competition for CRISPR Commercialization

By | May 1, 2014

Researchers stake their proprietary claim on the genome-editing technique.

0 Comments

image: Opinion: Pressured to Commercialize

Opinion: Pressured to Commercialize

By | May 28, 2012

Is the push for science to save the still flailing economy a threat to scientific research?

5 Comments

image: Universities Spawn More Startups

Universities Spawn More Startups

By | November 2, 2011

Despite the down economy, universities are ramping up their efforts to commercialize their research.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham